Possibilities and challenges for developing a successful vaccine for leishmaniasis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Possibilities and challenges for developing a successful vaccine for leishmaniasis
Authors
Keywords
Leishmaniasis, Immune response, Vaccine
Journal
Parasites & Vectors
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-05-12
DOI
10.1186/s13071-016-1553-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preclinical safety and tolerability of a repeatedly administered human leishmaniasis DNA vaccine
- (2015) O Riede et al. GENE THERAPY
- Studies on the protective efficacy of freeze thawed promastigote antigen of Leishmania donovani along with various adjuvants against visceral leishmaniasis infection in mice
- (2015) Ankita Thakur et al. IMMUNOBIOLOGY
- Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice
- (2015) Parna Bhattacharya et al. INFECTION AND IMMUNITY
- Decreased Frequency and Secretion of CD26 Promotes Disease Progression in Indian Post Kala-azar Dermal Leishmaniasis
- (2015) Shibabrata Mukherjee et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Leishmania tarentolae secreting the sand fly salivary antigen PpSP15 confers protection against Leishmania major infection in a susceptible BALB/c mice model
- (2015) A. Katebi et al. MOLECULAR IMMUNOLOGY
- Analysis of iron superoxide dismutase-encoding DNA vaccine on the evolution of theLeishmania amazonensisexperimental infection
- (2015) B. L. S. Campos et al. PARASITE IMMUNOLOGY
- Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum
- (2015) Jacqueline Araújo Fiuza et al. VACCINE
- Ability of immunodiagnostic tests to differentiate between dogs naturally infected with Leishmania infantum and Leishmune®-vaccinated dogs
- (2015) R. A. N. Ribeiro et al. VETERINARY RESEARCH COMMUNICATIONS
- Genetically Engineered Ascorbic acid-deficient Live Mutants of Leishmania donovani induce long lasting Protective Immunity against Visceral Leishmaniasis
- (2015) Sneha Anand et al. Scientific Reports
- Efficacy of Recombinant Canine Distemper Virus Expressing Leishmania Antigen against Leishmania Challenge in Dogs
- (2015) Ryuichi Miura et al. PLoS Neglected Tropical Diseases
- Recombinant NAD-dependent SIR-2 Protein of Leishmania donovani: Immunobiochemical Characterization as a Potential Vaccine against Visceral Leishmaniasis
- (2015) Rajendra K Baharia et al. PLoS Neglected Tropical Diseases
- Expression of Regulatory T Cells in Jejunum, Colon, and Cervical and Mesenteric Lymph Nodes of Dogs Naturally Infected with Leishmania infantum
- (2014) Maria M. Figueiredo et al. INFECTION AND IMMUNITY
- Cutting Edge: The Mechanism of Invariant NKT Cell Responses to Viral Danger Signals
- (2014) A. J. Tyznik et al. JOURNAL OF IMMUNOLOGY
- Interleukin 17A Acts Synergistically With Interferon γ to Promote Protection Against Leishmania infantum Infection
- (2014) Manuela Sales Lima Nascimento et al. JOURNAL OF INFECTIOUS DISEASES
- Immune response in susceptible BALB/c mice immunized with DNA encoding Lipophosphoglycan 3 ofLeishmania infantum
- (2014) L. Pirdel et al. PARASITE IMMUNOLOGY
- Enhanced expression of Toll-like receptors 2 and 4, but not 9, in spleen tissue from patients with visceral leishmaniasis
- (2014) R. Kumar et al. PARASITE IMMUNOLOGY
- Generation of growth arrested Leishmania amastigotes: A tool to develop live attenuated vaccine candidates against visceral leishmaniasis
- (2014) Angamuthu Selvapandiyan et al. VACCINE
- Immunization with the Leishmania infantum recombinant cyclophilin protein 1 confers partial protection to subsequent parasite infection and generates specific memory T cells
- (2014) G.M. Santos-Gomes et al. VACCINE
- CD4+FOXP3+ cells produce IL-10 in the spleens of dogs with visceral leishmaniasis
- (2014) Kathlenn Liezbeth Oliveira Silva et al. VETERINARY PARASITOLOGY
- Antibody responses induced by Leish-Tec®, an A2-based vaccine for visceral leishmaniasis, in a heterogeneous canine population
- (2014) Miriam C. de Souza Testasicca et al. VETERINARY PARASITOLOGY
- Enhanced Protective Efficacy of Nonpathogenic Recombinant Leishmania tarentolae Expressing Cysteine Proteinases Combined with a Sand Fly Salivary Antigen
- (2014) Farnaz Zahedifard et al. PLoS Neglected Tropical Diseases
- PKDL and Other Dermal Lesions in HIV Co-infected Patients with Leishmaniasis: Review of Clinical Presentation in Relation to Immune Responses
- (2014) Eduard E. Zijlstra PLoS Neglected Tropical Diseases
- Live Attenuated Leishmania donovani p27 Gene Knockout Parasites Are Nonpathogenic and Elicit Long-Term Protective Immunity in BALB/c Mice
- (2013) R. Dey et al. JOURNAL OF IMMUNOLOGY
- Animal Reservoirs of Visceral Leishmaniasis in India
- (2013) Niti Singh et al. JOURNAL OF PARASITOLOGY
- TLR2 and TLR4 in Cutaneous Leishmaniasis Caused byLeishmania major
- (2013) S. Tolouei et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Evaluation of immune responses and analysis of the effect of vaccination of the Leishmania major recombinant ribosomal proteins L3 or L5 in two different murine models of cutaneous leishmaniasis
- (2013) Laura Ramírez et al. VACCINE
- Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral Leishmaniasis
- (2013) Noushin Saljoughian et al. PLoS Neglected Tropical Diseases
- IL-17 Mediates Immunopathology in the Absence of IL-10 Following Leishmania major Infection
- (2013) Claudia Gonzalez-Lombana et al. PLoS Pathogens
- Killed but Metabolically Active Leishmania infantum as a Novel Whole-Cell Vaccine for Visceral Leishmaniasis
- (2012) Kevin W. Bruhn et al. Clinical and Vaccine Immunology
- Successful Therapy of Visceral Leishmaniasis With Curdlan Involves T-Helper 17 Cytokines
- (2012) Kuntal Ghosh et al. JOURNAL OF INFECTIOUS DISEASES
- Leishmaniasis Worldwide and Global Estimates of Its Incidence
- (2012) Jorge Alvar et al. PLoS One
- The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases
- (2011) Beckley K. Davis et al. Annual Review of Immunology
- Post-kala-azar dermal leishmaniasis: recent developments
- (2011) Sarman Singh et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Identification of TLR inducing Th1-responsive Leishmania donovani amastigote-specific antigens
- (2011) Ankita Srivastava et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Leishmaniasis: complexity at the host–pathogen interface
- (2011) Paul Kaye et al. NATURE REVIEWS MICROBIOLOGY
- Potency, Efficacy and Durability of DNA/DNA, DNA/Protein and Protein/Protein Based Vaccination Using gp63 Against Leishmania donovani in BALB/c Mice
- (2011) Saumyabrata Mazumder et al. PLoS One
- A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis
- (2011) Jaya Chakravarty et al. VACCINE
- Foxp3 and IL-10 Expression Correlates with Parasite Burden in Lesional Tissues of Post Kala Azar Dermal Leishmaniasis (PKDL) Patients
- (2011) Gajendra Kumar Katara et al. PLoS Neglected Tropical Diseases
- BALB/c Mice Infected with Antimony Treatment Refractory Isolate of Leishmania braziliensis Present Severe Lesions due to IL-4 Production
- (2011) Diego L. Costa et al. PLoS Neglected Tropical Diseases
- Evaluation of Ex Vivo Human Immune Response against Candidate Antigens for a Visceral Leishmaniasis Vaccine
- (2010) Rajiv Kumar et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Dichotomy of the human T cell response to Leishmania antigens. I. Th1-like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis
- (2010) M. KEMP et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Activity and turnover of eosinophil and neutrophil granulocytes are altered in visceral leishmaniasis
- (2010) Amir I. Elshafie et al. INTERNATIONAL JOURNAL FOR PARASITOLOGY
- Leishmaniasis vaccines: past, present and future
- (2010) Farrokh Modabber INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Applying TLR Synergy in Immunotherapy: Implications in Cutaneous Leishmaniasis
- (2010) V. S. Raman et al. JOURNAL OF IMMUNOLOGY
- Cytokine and transcription factor profiles in the skin of dogs naturally infected by Leishmania (Leishmania) chagasi presenting distinct cutaneous parasite density and clinical status
- (2010) Daniel Menezes-Souza et al. VETERINARY PARASITOLOGY
- Adaptive Immunity against Leishmania Nucleoside Hydrolase Maps Its C-Terminal Domain as the Target of the CD4+ T Cell–Driven Protective Response
- (2010) Dirlei Nico et al. PLoS Neglected Tropical Diseases
- IL-17 and Th17 Cells
- (2009) Thomas Korn et al. Annual Review of Immunology
- Developmental plasticity of Th17 and Treg cells
- (2009) Yun Kyung Lee et al. CURRENT OPINION IN IMMUNOLOGY
- IL-27 Regulates IL-10 and IL-17 from CD4+ Cells in Nonhealing Leishmania major Infection
- (2009) C. F. Anderson et al. JOURNAL OF IMMUNOLOGY
- Ubiquitin Conjugation of Open Reading Frame F DNA Vaccine Leads to Enhanced Cell-Mediated Immune Response and Induces Protection against Both Antimony-Susceptible and -Resistant Strains of Leishmania donovani
- (2009) A. Sharma et al. JOURNAL OF IMMUNOLOGY
- Immunization with the DNA-Encoding N-Terminal Domain of Proteophosphoglycan of Leishmania donovani Generates Th1-Type Immunoprotective Response against Experimental Visceral Leishmaniasis
- (2009) M. Samant et al. JOURNAL OF IMMUNOLOGY
- IL-27 Is a Key Regulator of IL-10 and IL-17 Production by Human CD4+ T Cells
- (2009) G. Murugaiyan et al. JOURNAL OF IMMUNOLOGY
- Identification of Novel Leishmania donovani Antigens that Help Define Correlates of Vaccine-Mediated Protection in Visceral Leishmaniasis
- (2009) Sudipta Bhowmick et al. PLoS One
- Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis
- (2009) Amir Mizbani et al. VACCINE
- Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis—A meta-analysis
- (2009) Sassan Noazin et al. VACCINE
- Immunogenicity of candidate chimeric DNA vaccine against tuberculosis and leishmaniasis
- (2009) Ayan Dey et al. VACCINE
- Optimized subunit vaccine protects against experimental leishmaniasis
- (2009) Sylvie Bertholet et al. VACCINE
- Cellular and humoral responses induced by Leishmania histone H2B and its divergent and conserved parts in cutaneous and visceral leishmaniasis patients, respectively
- (2009) A. Meddeb-Garnaoui et al. VACCINE
- Live attenuated Leishmania vaccines: a potential strategic alternative
- (2008) Ricardo Silvestre et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Kinesin Motor Domain of Leishmania donovani as a Future Vaccine Candidate
- (2008) A. Dey et al. Clinical and Vaccine Immunology
- Function of Nod-like receptors in microbial recognition and host defense
- (2008) Luigi Franchi et al. IMMUNOLOGICAL REVIEWS
- Expression and characterization of a recombinant kinesin antigen from an old Indian strain (DD8) of Leishmania donovani and comparing it with a commercially available antigen from a newly isolated (KE16) strain of L. donovani
- (2008) Ramu Sivakumar et al. INFECTION GENETICS AND EVOLUTION
- Immunogenicity of HSP-70, KMP-11 and PFR-2 leishmanial antigens in the experimental model of canine visceral leishmaniasis
- (2008) Eugenia Carrillo et al. VACCINE
- Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individuals
- (2008) Naghmeh Khoshgoo et al. VACCINE
- First generation leishmaniasis vaccines: A review of field efficacy trials
- (2008) Sassan Noazin et al. VACCINE
- Vaccines for leishmaniasis in the fore coming 25 years
- (2008) Clarisa B. Palatnik-de-Sousa VACCINE
- A prime/boost DNA/Modified vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasis
- (2008) Connor Carson et al. VACCINE
- Tissue granuloma structure-function in experimental visceral leishmaniasis
- (2003) Henry W. Murray INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now